Amersham Health has received European Union approval to market its Optison cardiac ultrasound contrast agent. The London-based firm, which has been marketing Optison in North America since 2000, will begin selling the agent in Europe this month.
By AuntMinnie.com staff writersJune 6, 2002
Related Reading
Amersham inks supply deal with Novation, May 29, 2002
Amersham shows uptick in Q1 numbers, April 29, 2002
Amersham launches online encyclopedia, March 4, 2002
Amersham inks deal with Pfizer, February 1, 2002
Amersham expands radiopharmacy network, January 23, 2002
Copyright © 2002 AuntMinnie.com